115. The Future of Therapy Is Psychedelic

He’s an economist who studies even weirder things than Steve. They discuss whether economics is the best of the social sciences, and why it’s a good idea to get a tattoo of a demand curve on your bicep. This episode originally aired on June 11th, 2021. Hosted by Simplecast, an Ad ...  Show more

The African-born economist has written four bestselling books, including Dead Aid, which Bill Gates described as “promoting evil.” In her new book about corporate boards, Dambisa uses her experience with global corporations to explore how they can better meet society’s demands. A ...  Show more

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ...  Show more

Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocy ...  Show more

In this episode, Rick Doblin, founder and executive director of MAPS, discusses MDMA, a molecule that has (at a minimum) revolutionary therapeutic benefits for PTSD, but arguably could have, at the highest order, a lasting impact on humanity's ability to peacefully coexist. Ri ...

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ...  Show more